Molina Healthcare stock jumps 14% after Q1, guidance affirmed

Molina Healthcare shares rallied roughly 14% after the company released first-quarter 2026 results that beat expectations on an adjusted basis and reaffirmed its full-year adjusted earnings guidance. Investors reacted to the combination of an EPS beat and management’s cautious but steady outlook for the year.

According to the April 22, 2026 press release, Molina reported adjusted earnings per share of $2.35 for the quarter, with premium revenue near $10.2 billion and a consolidated Medical Care Ratio (MCR) of 91.1%. The company reiterated guidance for full-year adjusted EPS of at least $5.00 and expected premium revenue of approximately $42 billion. These reported figures and the guidance reaffirmation were the proximate drivers of the buying interest.

Market data showed a notable intraday move and higher-than-normal volume for Molina shares, with intraday highs extending into the $170–$178 range and a double-digit percentage gain by the close. The price action reflects traders responding to a clearer near-term earnings trajectory after a period of headline-driven volatility.

The backdrop to the rally includes earlier profit warnings and guidance reductions that had put the stock under pressure; Molina cut its forecasts in prior months amid rising medical costs across government-backed plans, which earlier prompted sharp share declines. That recent history helps explain why a single-quarter beat and a guidance reaffirmation produced an outsized positive market reaction.

Looking ahead, analysts say the key questions are whether the favorable cost trends observed in the quarter are sustainable and whether Molina can translate them into durable margin recovery. Management’s upcoming investor-day disclosures and subsequent quarter updates will be watched closely; if medical-cost trends continue to moderate, sentiment and analyst estimates could be revised higher, but persistent cost pressures would likely reintroduce volatility.